To validate the association between PD-L1 expression levels and CD56bright NK cells in EGFR-mutated NSCLC, we analyzed baseline peripheral blood samples from 10 patients with high PD-L1 expression and 16 patients with low PD-L1 expression. This evidence concerns the gene EGFR and non-small cell lung carcinoma.